Showing results (181-190 of 259) with videos related to
Sort By:
Pageof 26
Oncogene|October 11, 2001
Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agentsV Bergoglio, Y Canitrot, L Hogarth, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopyR Goel, P A Andrews, C E Pfeifle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinomaS Kirmani, W E Lucas, S Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60E Kimura, R E Enns, J E Alcaraz, et al.Cancer Research|December 15, 1992
Modulation of cisplatin resistance in human malignant melanoma cellsE F McClay, K D Albright, J A Jones, et al.Biochemical Pharmacology|March 23, 1999
Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cellsK V Ferry, D Fink, S W Johnson, et al.Genes, Chromosomes & Cancer|April 1, 1997
Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cellsV M Wasenius, A Jekunen, O Monni, et al.European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Improved targeting of platinum chemotherapeutics. the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour modelsX Lin, Q Zhang, J R Rice, et al.Journal of the National Cancer Institute|August 1, 1980
Thymidine as a chemotherapeutic agent: pharmacologic, cytokinetic, and biochemical studies in a patient with T-cell acute lymphocytic leukemiaS B Howell, B Chu, J Mendelsohn, et al.Obstetrics and Gynecology|May 1, 1993
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancerS C Plaxe, P S Braly, J L Freddo, et al.Pageof 26